Table 2.
Ikeda_2007a | Maldarelli_2014b | Wagner_2014c | Imamichi_2014d |
---|---|---|---|
BACH2 (44) | BACH2 (25) | BACH2 (16) | BACH2 (4) |
MKL2 (4) | MKL2 (122) | MKL2 (4) | SMC5 (17) |
STAT5B (16) | STAT5B (18) | SATA5B (4) | |
SMG1 (9) | CYTH1 (7) | XAF1 (13) | |
RARRES3 (3) | RPTOR (7) | ARHGP35 (7) | |
ZGPAT (2) | TAOK1 (8) | CREBBP (3) | |
EIF4G (3) | TNRC6B (7) | MOB1A (2) | |
SP192 (2) | PRKCB (7) | MGA (3) | |
hmRNA (8) | MKL1 (9) | GPC3 (2) | |
SPTANI (2) | MAP4 (7) | CBL (2) | |
SPATS2 (4) | PAK2 (10) | PHF (9) | |
TOP1 (2) | NSD1 (7) | APOBEC3C (15) | |
DUSP16 (2) | KIAA0319L (12) | MDC1 (57) | |
SOX5 (4) | NFATC3 (7) | HSF5 (10) | |
NRF1 (2) | HORMAD2 (64) | RALGPS2 (7) | |
BTBD9 (6) | OXCT1 (5) | ||
UBE2H (8) | SMG6 (14) | ||
TBCD (14) |
Genes associated with cell growth and cell proliferation (italics), genes associated with mitosis (bold italics), genes associated with cancer (bold)
aLongitudinal analysis of IS in seven patients on therapy (>2 years), detected in each gene
bLongitudinal analysis of IS in five well-suppressed patients on cART (>10 years); only genes with >5 integrants are included in the table
cLongitudinal analysis of IS in three well-suppressed patients on cART (>10 years)
dLongitudinal analysis of IS in one patient on therapy (≥15 years)